Therapy has been approved to treat advanced NTRK fusion-positive solid tumours

Agreement will utilise Oxford Biomedica’s LentiVector platform

Drug approved to treat major depressive disorder with acute suicidal ideation or behaviour

Updated Date: Mon, 27 Jul 2020 00:00:00 EDT

Updated Date: Mon, 27 Jul 2020 00:00:00 EDT

Updated Date: Mon, 27 Jul 2020 00:00:00 EDT

Updated Date: Mon, 27 Jul 2020 00:00:00 EDT

Updated Date: Mon, 27 Jul 2020 00:00:00 EDT

I understand from Habib’s article that Sweden’s decision not to mandate lockdown has been a failure because the […]

In a first, MorphoSys, Incyte win Monjuvi FDA nod in lymphoma to challenge Roche’s Polivy aliu Mon, 08/03/2020 […]